| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/25/2001 | CA2379058A1 Pseudomycin prodrugs |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378202A1 New compounds |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 01/24/2001 | EP1070711A2 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 01/24/2001 | EP1070707A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070059A1 Chromanone and thiochromanone derivatives |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/24/2001 | EP1069898A1 Topical antiseptic compositions and methods |
| 01/24/2001 | EP1069886A1 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance |
| 01/24/2001 | EP1069884A1 Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids |
| 01/24/2001 | EP1069883A1 Cholesterol sulfate compositions for enhancement of stratum corneum function |
| 01/24/2001 | EP0868192A4 Fast drying, film forming iodine release solution |
| 01/24/2001 | EP0821673B1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | CN1281443A Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281433A Hydroxamic acid derivatives as matrix metalloprotease (MMP) inhibitors |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281354A Topical compositions for regulating oily/shiny appearance of skin |
| 01/24/2001 | CN1280853A Baicao skin lotion and its preparing process |
| 01/24/2001 | CN1280840A Chinese-medicinal plaster for treating spontaneous or night sweating and its preparing process |
| 01/24/2001 | CN1280838A Exterior-applied antalgic ointment for treating burn and scald and its preparing process |
| 01/24/2001 | CN1280822A Skin-care product |
| 01/24/2001 | CN1280820A Shampoo |
| 01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
| 01/24/2001 | CN1060958C External-use Chinese medicine |
| 01/24/2001 | CN1060955C Plaster for treating wound |
| 01/24/2001 | CN1060953C Medicine for curing psoriasis |
| 01/24/2001 | CN1060949C 'Zhongluo' hair regenerating capsule |
| 01/24/2001 | CN1060947C Use of buttercup for preparing medicine for curing scald |
| 01/23/2001 | US6177579 Process for the preparation of 13-cis-retinoic acid |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177470 Prostaglandin synthesis |
| 01/23/2001 | US6177455 Administering a nitrogen-containing heterocyclic compound |
| 01/23/2001 | US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177273 Antisense modulation of integrin-linked kinase expression |
| 01/23/2001 | US6177105 LYCD compositions and therapy |
| 01/23/2001 | US6177092 Self-foaming cleansing systems |
| 01/23/2001 | US6177066 Mixtures of solidifying agent and deodorants |
| 01/23/2001 | CA2191790C Biaromatic compounds containing an adamantyl group in para position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 01/21/2001 | CA2314373A1 Heteroaryl-substituted pyrrole derivatives, their preparation and their thereapeutic uses |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004207A1 Preparations containing no cross-linking agents |
| 01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 01/18/2001 | WO2001004119A1 Amido spiropiperidines promote the release of growth hormone |
| 01/18/2001 | WO2001004113A2 Process for the preparation of paroxetine and synthetic intermeditates thereof |
| 01/18/2001 | WO2001004111A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 01/18/2001 | WO2001004102A1 Quinazoline derivatives |
| 01/18/2001 | WO2001004099A1 Benzoylpyridazines |
| 01/18/2001 | WO2001004089A1 Vitamin d3 analogs |
| 01/18/2001 | WO2001003749A1 Herb medicine composition to be contained in sanitary materials for infants |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003712A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 01/18/2001 | WO2001003711A1 Method for isolating lipophilic materials out of vegetable and/or or animal material |
| 01/18/2001 | WO2001003696A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | WO2001003688A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 01/18/2001 | WO2001003679A1 Method for closing and healing wound surfaces, variants, coating, variants and adhesive bandage and variants thereof for realising the same |
| 01/18/2001 | WO2001003664A1 Stabilized ascorbic acid, composition, and method of use |
| 01/18/2001 | WO2001003657A1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000062744A3 Skin care compositions containing combination of skin care actives |
| 01/18/2001 | WO2000062743A3 Skin care compositions containing combination of skin care actives |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000037067A3 Sensitizing agents for the treatment of skin lesions |
| 01/18/2001 | WO2000034245A3 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO1999050403A3 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 01/18/2001 | DE19933173A1 Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶ |
| 01/18/2001 | DE19932197A1 Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung Topically applied agents with protective and regenerative effect |
| 01/18/2001 | DE19932075A1 Vernetzerfreie Zubereitungen Vernetzerfreie preparations |
| 01/18/2001 | CA2379373A1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and .beta.1 integrins |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378595A1 Benzoylpyridazines |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378291A1 Quinazoline derivatives |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2377502A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/17/2001 | EP1069142A1 Water soluble polymers and their use in cosmetic and pharmaceutic products |
| 01/17/2001 | EP1068865A1 Use of 4,6-dimethoxy-indole 2 carboxylic acid or derivatives thereof for seborrhea treatment |
| 01/17/2001 | EP1068864A1 Use of at least a hydroxystilbene as a glycation inhibitor |
| 01/17/2001 | EP1068858A1 Use of 4,6-dimethoxyindole-2-carboxylic acid for stimulating or inducing hair growth and/or arresting hair loss |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068187A1 Pyrazole inhibitors of cytokine production |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1067939A1 Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways |